The Valley Desk

Clinical trial reportCancerPublished

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer
Published
Subject terms
Humans; Rhabdomyosarcoma; Medulloblastoma; Neuroblastoma; Cerebellar Neoplasms; Pyrazoles; Pyrimidinones; Cell Cycle Proteins; Antineoplastic Combined Chemotherapy Protocols; Child; Protein-Tyrosine Kinases; Irinotecan
PubMed ID
37081608
PubMed Central ID
PMC10628947
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal